In the Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke trial, a robust relation between speed of reperfusion and outcome was observed—every 6-minute delay in symptom onset to reperfusion in the stent retriever arm was associated with 1–1.5 fewer functionally independent outcomes at 90 days among every 100 patients treated.
To study the relationship between functional independence and time to reperfusion in the Solitaire with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial in patients with disabling acute ischemic stroke who underwent endovascular therapy plus intravenous tissue plasminogen activator (tPA) administration versus tPA administration alone and to investigate variables that affect time spent during discrete steps.
Materials and Methods
Data were analyzed from the SWIFT PRIME trial, a global, multicenter, prospective study in which outcomes were compared in patients treated with intravenous tPA alone or in combination with the Solitaire device (Covidien, Irvine, Calif). Between December 2012 and November 2014, 196 patients were enrolled. The relation between time from (a) symptom onset to reperfusion and (b) imaging to reperfusion and clinical outcome was analyzed, along with patient and health system characteristics that affect discrete steps in patient workflow. Multivariable logistic regression was used to assess relationships between time and outcome; negative binomial regression was used to evaluate effects on workflow. The institutional review board at each site approved the trial. Patients provided written informed consent, or, at select sites, there was an exception from having to acquire explicit informed consent in emergency circumstances.
In the stent retriever arm of the study, symptom onset to reperfusion time of 150 minutes led to 91% estimated probability of functional independence, which decreased by 10% over the next hour and by 20% with every subsequent hour of delay. Time from arrival at the emergency department to arterial access was 90 minutes (interquartile range, 69–120 minutes), and time to reperfusion was 129 minutes (interquartile range, 108–169 minutes). Patients who initially arrived at a referring facility had longer symptom onset to groin puncture times compared with patients who presented directly to the endovascular-capable center (275 vs 179.5 minutes, P < .001).
Fast reperfusion leads to improved functional outcome among patients with acute stroke treated with stent retrievers. Detailed attention to workflow with iterative feedback and aggressive time goals may have contributed to efficient workflow environments.
© RSNA, 2016
- 1. . Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol 2014;13(6):567–574. Crossref, Medline, Google Scholar
- 2. . Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR Thrombectomy for Acute Revascularization study. Stroke 2014;45(7):2024–2029. Crossref, Medline, Google Scholar
- 3. . Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2434–2435. Medline, Google Scholar
- 4. ;
SYNTHESIS Expansion Investigators. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2433–2434. Medline, Google Scholar
- 5. . Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(25):2432–2433. Medline, Google Scholar
- 6. . Evaluation of interval times from onset to reperfusion in patients undergoing endovascular therapy in the Interventional Management of Stroke III trial. Circulation 2014;130(3):265–272. Crossref, Medline, Google Scholar
- 7. . Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355(22):2308–2320. Crossref, Medline, Google Scholar
- 8. . Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke. Int J Stroke 2015;10(3):439–448. Crossref, Medline, Google Scholar
- 9. . Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med 2015;372(24):2285–2295. Crossref, Medline, Google Scholar
- 10. . Ultrashort imaging to reperfusion time interval arrests core expansion in endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013;5(Suppl 1):i58–i61. Crossref, Medline, Google Scholar
- 11. . Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 2013;309(23):2480–2488. Crossref, Medline, Google Scholar
- 12. . Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73(13):1066–1072. Crossref, Medline, Google Scholar
- 13. . Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 2011;42(6):1626–1630. Crossref, Medline, Google Scholar
- 14. . Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of Neurointerventional Surgery. J Neurointerv Surg 2015 Aug 31. [Epub ahead of print] Google Scholar
- 15. . Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 2015;372(11):1019–1030. Crossref, Medline, Google Scholar
Article HistoryReceived January 25, 2016; revision requested February 4; revision received February 22; accepted February 24; final version accepted March 10.
Published online: Apr 19 2016
Published in print: June 2016